Immunotherapy of advanced refractory multiple myeloma with idiotype-pulsed dendritic cells (Mylovenge).

被引：0
|
作者：
MacKenzie, M
Peshwa, MV
Wun, T
Wolf, J
Mason, J
Caggiano, V
Redfern, C
Strang, G
Valone, F
机构：
[1] Sacramento Med Fdn, Ctr Blood, Sacramento, CA USA
[2] Dendreon Corp, Seattle, WA USA
[3] Univ Calif Davis, Sacramento, CA 95817 USA
[4] Alta Bates Hosp, Berkeley, CA USA
[5] Scripps Clin, La Jolla, CA USA
[6] Sutter Canc Ctr, Sacramento, CA USA
[7] Sidney Kimmel Canc Ctr, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
713
引用
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [41] Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research
    Bogen, Bjame
    Ruffini, Pier Adelchi
    Corthay, Alexandre
    Fredriksen, Agnete B.
    Froyland, Marianne
    Lundin, Katrin
    Rosjo, Egil
    Thompson, Keith
    Massaia, Massimo
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (07): : 941 - 948
  • [42] Pulsed oral dexamethasone in relapsed and refractory multiple myeloma
    Smith, AG
    Crofts, SE
    WhatelySmith, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1148 - 1148
  • [43] Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
    Liso, A
    Stockerl-Goldstein, KE
    Auffermann-Gretzinger, S
    Benike, CJ
    Reichardt, V
    van Beckhoven, A
    Rajapaksa, R
    Engleman, EG
    Blume, KG
    Levy, R
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 621 - 627
  • [44] Efficient uptake of myeloma idiotype proteins by dendritic cells derived from myeloma patients.
    Butch, A
    Barlogie, B
    Kelly, K
    Munshi, N
    [J]. FASEB JOURNAL, 1999, 13 (04): : A276 - A276
  • [45] Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
    Liso, A
    Stockerl-Goldstein, KE
    Reichardt, VL
    Okada, CY
    Benike, CJ
    Engleman, EG
    Blume, KG
    Levy, R
    [J]. BLOOD, 1998, 92 (10) : 105A - 105A
  • [46] Protective anitiumor immunity induced by pulsed dendritic cells against established multiple myeloma
    Zeis, M
    Uharek, L
    Glass, B
    Krönke, M
    Steinmann, J
    Schmitz, N
    [J]. EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 87 - 87
  • [47] Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
    Shinde, Prajakta
    Melinkeri, Sameer
    Santra, Manas Kumar
    Kale, Vaijayanti
    Limaye, Lalita
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [48] Deletion of idiotype (Id)-specific T cells in multiple myeloma
    Bogen, B
    Schenck, K
    Munthe, LA
    Dembic, Z
    [J]. ACTA ONCOLOGICA, 2000, 39 (07) : 783 - 788
  • [49] Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
    Ritchie, D
    Hermans, I
    Yang, JP
    Walton, J
    Matthews, K
    Carter, J
    Findlay, M
    Dady, P
    Rawson, P
    Ronchese, F
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 675 - 682
  • [50] Optimizing dendritic cell-based immunotherapy in multiple myeloma
    Yi, Q
    Desikan, R
    Barlogie, B
    Munshi, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 297 - 305
12345